APHL 2 LIMITED
Get an alert when APHL 2 LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-05 (in 4mo)
Last made up 2025-08-22
Watchouts
None on the register
Cash
£9M
-12% vs 2023
Net assets
£50M
+56.5% highest in 4 filed years
Employees
100
+26.6% highest in 6 filed years
Profit before tax
£26M
+20.9% vs 2023
Net assets
6-year trend · vs Industrials median
Accounts
6-year trend · latest reflected 2024-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | £99,113,709 | £114,959,408 | |
| Operating profit | — | — | — | — | £21,215,504 | £25,529,439 | |
| Profit before tax | — | — | — | — | £21,315,824 | £25,766,281 | |
| Net profit | £2,474,133 | £4,958,587 | — | £17,848,827 | £20,528,903 | £23,929,520 | |
| Cash | £5 | £48,554 | £97,830 | £189,907 | £9,854,905 | £8,677,095 | |
| Total assets less current liabilities | £5,083,935 | £4,965,659 | — | — | £33,090,482 | £51,306,666 | |
| Net assets | £2,474,135 | — | — | — | £32,070,504 | £50,205,548 | |
| Equity | — | — | — | — | £32,070,504 | £50,205,548 | |
| Average employees | 4 | 5 | 6 | 2 | 79 | 100 | |
| Wages | £0 | £0 | £0 | £0 | £4,016,595 | £6,302,015 | |
| Directors' remuneration | — | — | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+16%
£99,113,709 £114,959,408
-
Cash
-12%
£9,854,905 £8,677,095
-
Net assets
+56.5%
£32,070,504 £50,205,548
highest in 3 filed years
-
Employees
+26.6%
79 100
highest in 6 filed years
-
Operating profit
+20.3%
£21,215,504 £25,529,439
-
Profit before tax
+20.9%
£21,315,824 £25,766,281
-
Wages
+56.9%
£4,016,595 £6,302,015
highest in 6 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | — | 21.4% | 22.2% | |
| Net margin | — | — | — | — | 20.7% | 20.8% | |
| Return on capital employed | — | — | — | — | 64.1% | 49.8% | |
| Current ratio | — | — | — | — | 1.87x | 2.05x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- TC Group
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Group structure
- APHL 2 LIMITED · parent
- Aspire Pharma Limited 100%
- Dermato Logical Limited 100%
- Cenoté Pharma Limited 100%
- Aspire Pharma GmbH 100%
- APIE Limited 100%
Significant events
- “Aspire made two strategic acquisitions in 2024 in acquiring Cenote Pharma Ltd & the assets of Canute Pharma Ltd, both bringing complementary products to the Aspire portfolio that align to our strategy in providing cost effective niche medicines to patients, healthcare professionals and providers.”
- “In 2024 Aspire launch 10+ new products on the back of licences approvals.”
- “On 7 March 2024 Aspire Pharma Limited acquired Cenoté Pharma Limited, including the company's German subsidiary Cenoté Pharma GmbH.”
- “APIE Limited was incorporated as a subsidiary of Aspire Pharma Limited on 17 October 2024.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BUCKLEY, Gary David | Secretary | 2020-06-15 | — | — |
| BUCKLEY, Gary David | Director | 2020-06-15 | Feb 1986 | British |
| CONDON, Richard Michael | Director | 2023-04-28 | Aug 1976 | British |
| MAY, Jonathan Charles | Director | 2020-06-15 | Apr 1970 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| FRASER-PYE, Jacqueline Elizabeth | Secretary | 2019-09-19 | 2022-03-11 |
| ROBERTS, Debra Joy | Secretary | 2019-09-19 | 2020-05-31 |
| FRASER-PYE, Graham Julian | Director | 2018-08-23 | 2021-09-03 |
| JACOBSON, Ian | Director | 2019-09-19 | 2021-09-03 |
| PODOLSKY, Craig | Director | 2020-06-15 | 2021-09-03 |
| ROBERTS, Debra Joy | Director | 2019-09-19 | 2020-05-30 |
| ROBERTS, Mark Derek | Director | 2019-09-19 | 2021-09-03 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Aspire Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-09-03 | Ceased 2022-11-28 |
| Ian Jacobson | Individual | Shares 25–50%, Voting 25–50% | 2019-09-19 | Ceased 2021-09-03 |
| Mr Graham Julian Fraser-Pye | Individual | Shares 25–50%, Voting 25–50% | 2018-08-23 | Ceased 2021-09-03 |
Filing timeline
Last 20 of 57 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-01-10 MA Memorandum articles
- 2024-01-10 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-09-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-03 | AA | accounts | Accounts with accounts type group | |
| 2024-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-25 | AA | accounts | Accounts with accounts type group | |
| 2024-01-10 | MA | incorporation | Memorandum articles | |
| 2024-01-10 | RESOLUTIONS | resolution | Resolution | |
| 2023-08-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-10 | AA | accounts | Accounts with accounts type group | |
| 2023-05-02 | CH01 | officers | Change person director company with change date | |
| 2023-05-02 | CH01 | officers | Change person director company with change date | |
| 2023-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-06 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2023-02-06 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2022-12-06 | PSC08 | persons-with-significant-control | Notification of a person with significant control statement | |
| 2022-12-06 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-08-26 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-07-08 | AA | accounts | Accounts with accounts type group | |
| 2022-03-11 | TM02 | officers | Termination secretary company with name termination date | |
| 2021-12-08 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2021-09-20 | PSC02 | persons-with-significant-control | Notification of a person with significant control |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.